Long-Term Safety of Omalizumab in Children with Asthma and/or Chronic Spontaneous Urticaria: A 4-Year Prospective Study in Real Life

Conclusions: Long-term "real-life" treatment with omalizumab in children appears well tolerated. Its safety and efficacy profile makes omalizumab an excellent alternative in severe asthma and CSU in children.PMID:37511681 | DOI:10.3390/jpm13071068

Source: Herpes - July 29, 2023 Category: Infectious Diseases Authors: Francesca Galletta Lucia Caminiti Cecilia Lugar à Simone Foti Randazzese Paolo Barraco Federica D'Amico Pierangela Irrera Giuseppe Crisafulli Sara Manti Source Type: research